Use of secukinumab to inhibit structural damage in axial spondyloarthritis patients
CA3319533A1Pending Publication Date: 2026-09-21NOVARTIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3319533
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-10-19
- Filing Date
- 2016-10-14
- Publication Date
- 2026-09-21
Need to check novelty before this filing date? Find Prior Art
No text content released.